Federal Agency · Defense Health Agency Contracting Activity - DHACA
DoW Lupus, Transformative Vision Development Award
Last updated: August 25, 2026
Posted May 5, 2026
Funding
Funding amount not specified
Closes
August 24, 2026
NAICS
541715
Similar grants still open
- FY2026 Implementation of the Quagga and Zebra Mussel Action Plan (QZAP) in the Western United StatesFish and Wildlife Service · closes October 24, 2026
- Assisting Specialty Crop Exports: Low Oxygen Storage and Packaging Systems for U.S. Tree Nuts with Phytosanitary TraceabilityForeign Agricultural Service · closes October 26, 2026
- Climate Program Office (CPO) FY2026 Earth System Science and Services PartnershipDOC NOAA - ERA Production · closes October 26, 2026
- Long-term health outcomes of people living with spina bifidaCenters for Disease Control - NCBDDD · closes October 26, 2026
- ROSES25: D.8 Habitable Worlds Observatory Precursor Science InvestigationNASA Headquarters · closes October 26, 2026
- Strengthening Bosnia and Herzegovina’s Organized Crime Specialized Departments for Organized Crime Through Expert Advisory SupportU.S. Mission to Bosnia and Herzegovina · closes October 27, 2026
- OJP FY 2026 Special Attorneys Program Round 10Bureau of Justice Assistance · closes October 28, 2026
- NASA Innovative Advanced Concepts (NIAC) Phase INASA Headquarters · closes October 28, 2026
Summary: This funding mechanism supports planning and development activities and pilot studies that will generate preliminary data and demonstrate feasibility for achieving the aims of a future interventional study. Successful studies may be submitted to a future Lupus Research Program (LRP) Transformative Vision Award (TVA), or equivalent, for funding consideration (See Funding Opportunity Number HT942526LRPTVA for additional information). Research must address at least one of the fiscal year 2026 (FY26) LRP Transformative Vision Development Award (TVDA) focus areas. This funding mechanism allows for phase 0/1 clinical trials, if appropriate. The mechanism does not allow for phase 2/3 clinical trials or animal studies. Distinctive Features: • Preliminary data are permitted but not required. • Applications must include at least one lupus consumer advocate as a member of the research team. • An individual may be named as Principal Investigator (PI) on only one application per LRP award mechanism (Idea Award, Impact Award, TVDA, TVA), for a maximum of four applications to the FY26 LRP.
Eligibility
- Funded by Army
Award details
Applications close on August 24, 2026.
Categories
Not categorized
This grant is no longer accepting applications. Get matched to open grants like it, or browse the ones above.
See similar open grants ↑Applications closed — listing kept for reference.·Source: Grants.gov·Last seen Aug 23, 2026